✦ LIBER ✦

HLA-A2.1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo

✍ Scribed by Yu Kyeong Hwang; Nam Kyung Kim; Jung Min Park; Ki-young Lee; Won-Kyo Han; Hyung-Il Kim; Hong Seok Cheong

Book ID: 117431055
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 142 KB
Volume: 20
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(02)00297-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of SART3-derived peptides

Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypes

✍ Masaaki Ito; Shigeki Shichijo; Yoshiaki Miyagi; Terutada Kobayashi; Naotake Tsud 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB 👁 1 views

Cleavage and polyadenylation specificity

Cleavage and polyadenylation specificity factor (CPSF)-derived peptides can induce HLA-A2-restricted and tumor-specific CTLs in the majority of gastrointestinal cancer patients

✍ Yoshiaki Maeda; Masaaki Ito; Nanae Harashima; Tetsuya Nakatsura; Naoya Hida; Nob 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 357 KB 👁 1 views

## Abstract To identify CTL‐directed antigens in gastrointestinal cancer, we have investigated antigens recognized by the HLA‐A2‐restricted CTL line established from T cells infiltrating into colon cancer and report herein cleavage and polyadenylation specificity factor (CPSF) as a potent antigen h

Identification of Lck-derived peptides c

Identification of Lck-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with distant metastases

✍ Nobue Imai; Nanae Harashima; Masaaki Ito; Yoshiaki Miyagi; Mamoru Harada; Akira 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 132 KB 👁 1 views

The Lck protein (p56 lck ), a src family tyrosine kinase essential for T cell development and function, is aberrantly expressed in various types of cancers. We revealed recently that Lck can be a tumor antigen recognized by HLA-A24restricted and tumor-specific cytotoxic T lymphocytes (CTLs) of cance

Identification of a novel peptide derive

Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line

✍ Alexander B. H. Barker; Marco W. J. Schreurs; Gaalda Tafazzul; Annemiek J. De Bo 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 633 KB

## Abstract Cytotoxic T lymphocytes (CTL) reactive with human melanoma tumor cells occasionally display cross‐reactivity with normal melanocytes. Previously, we identified the melanocyte lineage‐specific antigen gp100 that is expressed by both melanoma cells and normal melanocytes, as a target anti

HLA-A2.1/Kb Transgenic Murine Dendritic

HLA-A2.1/Kb Transgenic Murine Dendritic Cells Transduced with an Adenovirus Encoding Human gp100 Process the Same A2.1-Restricted Peptide Epitopes as Human Antigen-Presenting Cells and Elicit A2.1-Restricted Peptide-Specific CTL

✍ Sixun Yang; Gerald P. Linette; Simonne Longerich; Bruce L. Roberts; Frank G. Hal 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Generation of human tumor-specific CTLs

Generation of human tumor-specific CTLs in HLA-A2.1–transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumors

✍ Angelos D. Gritzapis; Nectaria N. Sotiriadou; Michael Papamichail; Constantin N. 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 427 KB